Diagnosis and management of premenstrual disorders

BMJ

Volumn 342, Issue 7810, 2011, Pages

  O'Brien, Shaughn ^a   Rapkin, Andrea ^b   Dennerstein, Lorraine ^c   Nevatte, Tracy ^d  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DANAZOL; DIURETIC AGENT; DROSPIRENONE; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; FLUOXETINE; GONADORELIN AGONIST; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; PAROXETINE; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SPIRONOLACTONE; TIBOLONE; VENLAFAXINE;

DIAGNOSTIC TEST; DIET THERAPY; ENDOMETRIUM ABLATION; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; GENERAL PRACTICE; HEADACHE; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; INSOMNIA; LUTEAL PHASE; MOOD DISORDER; NAUSEA; OVARIECTOMY; OVULATION INHIBITION; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SIDE EFFECT; SWEATING; SYMPTOMATOLOGY; TREATMENT PLANNING; TREMOR;

FEMALE; HUMANS; PREMENSTRUAL SYNDROME;

EID: 79958703098     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d2994     Document Type: Review

References (28)

1. Halbreich U, Borenstein J, Pearlstein T, Kahn LS The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003;28:1-23. (Pubitemid 39658675)
2. O'Brien PM, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health 2011;14:13-21.
3. O'Brien S, Ismail K. History of the premenstrual disorders. In: O'Brien PM, Rapkin AJ, Schmidt PJ. The premenstrual syndromes: PMS and PMDD. Informa Healthcare, 2007.
4. Wyatt K, Dimmock P, Jones P, Obhrai M, O'Brien S. Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. BMJ 2001;323:776.
5. Ford O, Lethaby A, Roberts H, Mol BW. Progesterone for premenstrual syndrome. Cochrane Database Syst Rev 2009;2:CD003415.
6. Rapkin AJ, Chang LC, Reading AE. Comparison of retrospective and prospective assessment of premenstrual symptoms. Psychol Rep 1988;62:55-60. (Pubitemid 18080974)
7. Royal College of Obstetricians and Gynaecologists. Premenstrual syndrome. Management. Green-top guideline 48. RCOG Press, 2007. www.rcog.org.uk/files/ rcog-corp/uploadedfiles/ GT48ManagementPremensturalSyndrome.pdf.
8. Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Women's Ment Health 2003;6:203-9. (Pubitemid 37046015)
9. Dennerstein L, Lehert P, Keung LS, Pal SA, Choi D. A population-based survey of Asian women's experience of premenstrual symptoms. Menopause Int 2010;16:139-45.
10. Premenstrual dysphoric disorder. In: Diagnostic and statistical manual of mental disorders. 4th ed. American Psychiatric Press, 2000:771-4.
11. ACOG practice bulletin: premenstrual syndrome. Int J Gynaecol Obstet 2001;73:183-91.
12. 12Case AM, Reid RL. Effects of the menstrual cycle on medical disorders. Arch Intern Med 1998;158:1405-12. (Pubitemid 28317755)
13. Girman A, Lee R, Kligler B. An integrative medicine approach to premenstrual syndrome. Am J Obstet Gynecol 2003;188(suppl):S56-65.
14. Hunter MS, Ussher JM, Cariss M, Browne S, Jelley R, Katz M. Medical (fluoxetine) and psychological (cognitive-behavioural therapy) treatment for premenstrual dysphoric disorder. A study of treatment processes. J Psychosom Res 2002;53:811-7.
15. Wang M, Hammarbäck S, Lindhe BA, Bäckström T. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study. Acta Obstet Gynecol Scand 1995;74:803-8. (Pubitemid 26002180)
16. Brown J, O'Brien PMS, Marjoribanks J, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2009;2:CD001396.
17. Rapkin AJ, Winer SA. The pharmacologic management of premenstrual dysphoric disorder. Expert Opin Pharmacother 2008;9:1-17.
18. Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, et al. Expert guidelines for the treatment of severe PMS, PMDD, and co morbidities: the role of SSRIs. J Womens Health (Larchmt) 2006;15:57-69. (Pubitemid 43192864)
19. Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, et al. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review. Clin Ther 2009;31:1426-53.
20. Freeman EW, Rickels K, Sondheimer SJ, Polansky M. A double blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA 1995;274:51-7.
21. Landen M, Eriksson O, Sundblad C, Andersch B, Naessén T, Eriksson E. Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo. Psychopharmacology 2001;155:292-8. (Pubitemid 32477286)
22. Lopez LM, Kaptein AA, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev 2009;2:CD006586.
23. Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A. Efficacy of a new low dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol 2005;106:492-501. (Pubitemid 41208780)
24. Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 2005;72:414-21. (Pubitemid 41676830)
25. Wyatt KM, Dimmock PW, Ismail KM, O'Brien PMS. The effectiveness of GnRHa with and without "add-back" therapy in treating premenstrual syndrome: a meta-analysis. Br J Obstet Gynaecol 2004;111:585-93.
26. Hahn PM, Van Vugt DA, Reid RL. A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinology 1995;20:193-209. (Pubitemid 24366200)
27. Watson NR, Studd JW, Savvas M, Garnett T, Baber RJ. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 1989;2:730-2. (Pubitemid 19243126)
28. Magos AL, Brincat M, Studd JWW. Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study. BMJ 1986;292:1629-33. (Pubitemid 16097868)